Role of Central Neural NFkB and ER Stress in Obesity-induced Hypertension
中枢神经 NFkB 和 ER 应激在肥胖诱发的高血压中的作用
基本信息
- 批准号:9000211
- 负责人:
- 金额:$ 24.9万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2015
- 资助国家:美国
- 起止时间:2015-02-15 至 2018-01-31
- 项目状态:已结题
- 来源:
- 关键词:Angiopoietin-2Angiotensin IIAngiotensin Type 1a ReceptorAnimal ModelAnimalsAreaAutomobile DrivingBlood PressureBrainBrain regionCardiovascular DiseasesCardiovascular PhysiologyCardiovascular systemCell NucleusCell physiologyCellular StressChemicalsChronicDataDevelopmentDietDominant-Negative MutationEducational process of instructingEndoplasmic ReticulumEnvironmentFatty acid glycerol estersFoundationsFunctional disorderFutureGRP78 geneGene ExpressionGene TransferGenetic TranscriptionGenomicsHomeostasisHumanHypertensionHypothalamic structureImaging TechniquesInterventionInvestigationKnowledgeLaboratoriesLeadLeadershipLinkMapsMediatingMentorsMetabolicMetabolic DiseasesMolecularMolecular BiologyMolecular ChaperonesMusNF-kappa BNerveNeuraxisNeuronsNuclearNutritionalObesityPathogenesisPathway interactionsPhasePhysiologicalPhysiologyPlayPositioning AttributePreparationPrevalenceRegulationResearchResearch TrainingRobin birdRoleScientistSignal TransductionSignal Transduction PathwaySiteSubfornical OrganSynapsesTestingTimeTrainingTranslatingTranslational ResearchTranslationsUniversitiesViralViral Genesbasebioluminescence imagingcareer developmentendoplasmic reticulum stressfeedinggenomic toolsglobal healthin vivoinhibitor/antagonistinnovationinsightmouse modelneurogenic hypertensionneuroregulationnew therapeutic targetnovelparaventricular nucleuspreventreceptorrecombinaserelating to nervous systemresponsible research conductsensorskillsstressortranscription factor
项目摘要
PROJECT SUMMARY
Obesity is a major global health concern and is directly linked to the development of hypertension. Although a
number of factors may contribute, accumulating evidence from humans and animal models indicate that
excessive central sympathetic nerve activity (SNA) plays a pathogenic role in obesity-associated hypertension.
However, the mechanisms by which cellular stressors, such as nutritional excess, translate into sympathetic
overactivity and sustained elevations in arterial blood pressure remain unclear. A potential means is by
evoking long-term changes in gene expression in central nervous system (CNS) cardiovascular neurons
through the activation of inducible transcription factors, including nuclear factor kappa-B (NFκB). In this
regard, there is mounting evidence that angiotensinergic signaling and endoplasmic reticulum stress (ER
stress) within the brain are key mechanisms in diet-induced obesity (DIO); however the downstream molecular
effectors remain unclear. Our key preliminary findings show that DIO-hypertension is mediated by
angiotensinergic and ER stress mediated CNS mechanisms. We also provide exciting preliminary evidence
that high fat diet (HFD) feeding in mice induces ER stress and NFκB activation in critical CNS neuro-
cardioregulatory areas, including the subfornical organ (SFO) and paraventricular nucleus of the hypothalamus
(PVN). Using an approach that combines genomic interventions, innovative imaging techniques and
integrative cardiovascular physiological analysis in mice, we will test the overall hypothesis that Ang-II-
induced ER stress-mediated activation of NFκB in the SFO-PVN axis mediates neurogenic hypertension
induced by DIO.
In Specific Aim 1 we will comprehensively profile NFκB in the SFO-PVN axis during high fat diet (HFD)
feeding in mice. We will additionally examine a role for Ang-II-mediated mechanisms in driving NFκB
activation during the development of DIO-induced hypertension. Based on evidence that ER stress pathways
intersect directly with NFκB activation, in Specific Aim 2, we will examine a role for ER stress in mediating
NFκB activation in the SFO and PVN during HFD. Finally in Specific Aim 3, during the independent portion of
this proposal, the PI, Dr. Colin Young, will examine a functional role for NFκB in the SFO-PVN axis in
mediating DIO sympathetic overactivity and hypertension. These studies have direct translation relevance to
the setting of obesity-induced hypertension and build logically upon the PI's background in cardiovascular
physiology and sympathetic neural recordings in humans. Furthermore, the findings from these investigations
have the potential to significantly advance our understanding of the underlying molecular mechanisms driving
DIO neurogenic hypertension, and may provide novel therapeutic target(s) for the treatment of hypertensive
disease states. In addition, these studies have the potential to establish and advance a novel area of
research, while at the same time providing a strong training and future research framework for the PI. The PI
has extensive training in human neuro-cardiovascular regulation and is currently acquiring the knowledge and
skills for applying genomic tools to investigate molecular integrative cardiovascular/autonomic function in
mouse models of hypertension. As such, the mentored portion of this proposal (Aims 1 and 2) will uniquely
position the PI to pursue future independent investigations (Aim 3) at the crossroads of basic molecular and
integrative human translational research.
The laboratory of Dr. Robin Davisson is the premier venue for the PI to pursue additional mentored training
and perform the proposed studies, having been at the forefront of neural regulation and hypertension research
over the past decade. In addition to advanced training in genomics, molecular biology and whole animal
cardiovascular and autonomic physiology, the mentored guidance of Dr. Davisson and Cornell University
provide a superb opportunity for the progression of career development and training in the responsible conduct
of research. In addition to maintaining a strong research focus, the PI will pursue a number of exciting
opportunities at the laboratory and institutional level to enhance his maturation as an independent scientist;
including further development of leadership qualities, advancement of teaching skills and mentoring of
trainees. Overall, this novel and exciting proposal has the potential to lay a strong foundation for the next
independent phase of the PI.
项目总结
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Colin Neal Young其他文献
Colin Neal Young的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Colin Neal Young', 18)}}的其他基金
Brain endoplasmic reticulum stress in non-alcoholic fatty liver disease
非酒精性脂肪肝的脑内质网应激
- 批准号:
10224179 - 财政年份:2018
- 资助金额:
$ 24.9万 - 项目类别:
Forebrain-hypothalamic mechanisms in obesity-induced hypertension
肥胖引起的高血压的前脑-下丘脑机制
- 批准号:
10117094 - 财政年份:2018
- 资助金额:
$ 24.9万 - 项目类别:
Forebrain-hypothalamic mechanisms in obesity-induced hypertension
肥胖引起的高血压的前脑-下丘脑机制
- 批准号:
10330462 - 财政年份:2018
- 资助金额:
$ 24.9万 - 项目类别:
Brain endoplasmic reticulum stress in non-alcoholic fatty liver disease
非酒精性脂肪肝的脑内质网应激
- 批准号:
9770647 - 财政年份:2018
- 资助金额:
$ 24.9万 - 项目类别:
Brain endoplasmic reticulum stress in non-alcoholic fatty liver disease
非酒精性脂肪肝的脑内质网应激
- 批准号:
10443599 - 财政年份:2018
- 资助金额:
$ 24.9万 - 项目类别:
Role of Central Neural NFkB and ER Stress in Obesity-induced Hypertension
中枢神经 NFkB 和 ER 应激在肥胖诱发的高血压中的作用
- 批准号:
9014556 - 财政年份:2015
- 资助金额:
$ 24.9万 - 项目类别:
Role of Central Neural NFkB and ER Stress in Obesity-induced Hypertension
中枢神经 NFkB 和 ER 应激在肥胖诱发的高血压中的作用
- 批准号:
8581468 - 财政年份:2013
- 资助金额:
$ 24.9万 - 项目类别:
Role of Central Neural NFkB and ER Stress in Obesity-induced Hypertension
中枢神经 NFkB 和 ER 应激在肥胖诱发的高血压中的作用
- 批准号:
8717715 - 财政年份:2013
- 资助金额:
$ 24.9万 - 项目类别:
相似海外基金
Early endothelial function activation by angiotensin II receptor blockers prevents vascular damage in a model of diabetes
血管紧张素 II 受体阻滞剂早期激活内皮功能可预防糖尿病模型中的血管损伤
- 批准号:
493141 - 财政年份:2023
- 资助金额:
$ 24.9万 - 项目类别:
Clinical benefits and mechanism of action of angiotensin-II receptor blocker on Cardiovascular remodeling in patients with repaired coarctation of aorta
血管紧张素II受体阻滞剂对主动脉缩窄修复患者心血管重塑的临床疗效及作用机制
- 批准号:
10734120 - 财政年份:2023
- 资助金额:
$ 24.9万 - 项目类别:
Role of Angiotensin II in Bladder Dysfunction
血管紧张素 II 在膀胱功能障碍中的作用
- 批准号:
10707997 - 财政年份:2022
- 资助金额:
$ 24.9万 - 项目类别:
Regulation of nuclear calcium and ROS by Angiotensin II in heart cells. Régulation du calcium et ROS nucléaires par l'angiotensine II dans les cellules cardiaques.
血管紧张素 II 对心脏细胞中核钙和 ROS 的调节。
- 批准号:
RGPIN-2016-04414 - 财政年份:2022
- 资助金额:
$ 24.9万 - 项目类别:
Discovery Grants Program - Individual
Role of Angiotensin II in Bladder Dysfunction
血管紧张素 II 在膀胱功能障碍中的作用
- 批准号:
10555926 - 财政年份:2022
- 资助金额:
$ 24.9万 - 项目类别:
Regulation of nuclear calcium and ROS by Angiotensin II in heart cells. Régulation du calcium et ROS nucléaires par l'angiotensine II dans les cellules cardiaques.
血管紧张素 II 对心脏细胞中核钙和 ROS 的调节。
- 批准号:
RGPIN-2016-04414 - 财政年份:2021
- 资助金额:
$ 24.9万 - 项目类别:
Discovery Grants Program - Individual
Targeting cancer-associated fibroblasts and tumour hypoxia with angiotensin II receptor blockers
使用血管紧张素 II 受体阻滞剂靶向癌症相关成纤维细胞和肿瘤缺氧
- 批准号:
445961 - 财政年份:2021
- 资助金额:
$ 24.9万 - 项目类别:
Operating Grants
Intratubular Angiotensin II and AT1a Receptors in The Proximal Tubules: Roles in Hypertension and Kidney Injury
近曲小管中的管内血管紧张素 II 和 AT1a 受体:在高血压和肾损伤中的作用
- 批准号:
10164776 - 财政年份:2020
- 资助金额:
$ 24.9万 - 项目类别:
Novel Roles of Mitochondrial Angiotensin II in The Proximal Tubule of The Kidney
线粒体血管紧张素 II 在肾近端小管中的新作用
- 批准号:
10251271 - 财政年份:2020
- 资助金额:
$ 24.9万 - 项目类别:
Protection and organ injury by angiotensin II treatment for septic shock
血管紧张素II治疗感染性休克的保护作用和器官损伤
- 批准号:
20K09284 - 财政年份:2020
- 资助金额:
$ 24.9万 - 项目类别:
Grant-in-Aid for Scientific Research (C)